Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) EBIT Margin (2024 - 2025)

Nuvation Bio (NUVB) has disclosed EBIT Margin for 2 consecutive years, with 81.3% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 86323.0% to 81.3% in Q4 2025 year-over-year; TTM through Dec 2025 was 338.72%, a 718861.0% increase, with the full-year FY2025 number at 338.72%, up 718861.0% from a year prior.
  • EBIT Margin was 81.3% for Q4 2025 at Nuvation Bio, up from 430.14% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 81.3% in Q4 2025 to a low of 32779.44% in Q2 2024.